Previous close | 5.25 |
Open | 5.25 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 5.25 - 5.25 |
52-week range | 5.25 - 5.25 |
Volume | |
Avg. volume | N/A |
Market cap | 243.576M |
Beta (5Y monthly) | 0.18 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.20 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DGAP-News: MediClin AG / Key word(s): Quarterly / Interim StatementMediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure 02.05.2022 / 12:40 The issuer is solely responsible for the content of this announcement.Offenburg, 2 May 2022Group sales for the 1st quarter of 2022 significantly above the previous year's figureIn the 1st quarter of 2022, the continuous improvement in occupancy rates in the rehabilitation clinics, which began in the second half o
DGAP-News: MediClin AG / Key word(s): Annual Results/Annual Results30.03.2022 / 15:00 The issuer is solely responsible for the content of this announcement.Group sales and Group operating result in the second year of Corona above previous year - cautious outlook for year 2022MEDICLIN presented its figures for the 2021 financial year today. At today's virtual balance sheet press and analyst/investor conference, the Management Board commented on the business development in 2021 and commented on th
DGAP-News: MediClin AG / Key word(s): Preliminary Results28.02.2022 / 14:56 The issuer is solely responsible for the content of this announcement.Disclosure of the preliminary figures for the 2021 financial year - result above expectations thanks to better capacity utilization in the 4th quarter of 2021In the 2021 financial year, MEDICLIN achieved Group sales of EUR 673.1 mill. (previous year: EUR 659.9 mill.) and a consolidated operating result of EUR 11.6 mill. (previous year: EUR 0.2 mill.).G